Sera Prognostics, Inc. (SERA) income statement
SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30
$1.91−0.09 (-4.50%)
Close on Nov 18, 2026Market cap $75.35MP/E –Yield –
Sera Prognostics, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- -150.0%
- Operating margin
- -53282.9%
- Net margin
- -47475.7%
- Return on equity, FY2025
- -51.8%
Financial strength
- Current ratio
- 1.98
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 18.1%
Valuation
- P/E ratio
- –
- Price to sales
- 1076.41
- Price to book
- 1.27
- Dividend yield
- –
See a number that looks wrong?